Download PDF
Thromb Haemost 2000; 84(04): 733-734
DOI: 10.1055/s-0037-1614101
Letters to the Editor
Schattauer GmbH

Reactivation of Chronic Hepatitis C Virus Infection by Immunoadsorption in Factor VIII Inhibitor Haemophilia

Franz Rommel
2   From the Division of Haematology, Medizinische Klinik Innenstadt
,
Marcell Toepfer
2   From the Division of Haematology, Medizinische Klinik Innenstadt
,
Josef Eberle
1   Max-von-Pettenkofer-Institut, Ludwig-Maximilians-University, Munich, Germany
,
Helmut Schiffl
2   From the Division of Haematology, Medizinische Klinik Innenstadt
,
Michael Spannagl
2   From the Division of Haematology, Medizinische Klinik Innenstadt
,
Wolfgang Schramm
2   From the Division of Haematology, Medizinische Klinik Innenstadt
› Author Affiliations
Further Information

Publication History

Received 20 July 1999

Accepted after resubmission 22 May 2000

Publication Date:
11 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Freiburghaus C, Berntrop E, Ekman M, Gunnarson M, Kjellberg BM, Nilsson IM. Immunoadsorption for removal of inhibitors: update on treatments in Malmo-Lund between 1980 and 1995. Hemophilia 1998; 04: 16-20.
    CrossrefPubMedGoogle Scholar
  • 2 Knöbl P, Derfler K, Korninger L, Kapiotis S, Jäger U, Maier-Dobersberger T, Hörl W, Lechner K, Pabinger I. Elimination of aquirded factor VIII antibodies by exrtacorporeal antibody-based immunoadsorption (Ig-Thera sorb). Thromb Haemost 1995; 74: 1035-8.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Nilsson IM, Freiburghaus C. Apheresis. Adv Exp Med Biol 1995; 386: 175-84.
    PubMedGoogle Scholar
  • 4 Freedman J, Semple JW, Teitel J, Stewart K, Garvey B. Clinical and immunologic effects of staphylococcal protein A immunoadsorption therapy for inhibitor of factor VIII. Transfus Sci 1992; 13: 223-8.
    CrossrefPubMedGoogle Scholar
  • 5 Moulin A, Muller-Derlich J, Bieber F, Richter WO, Frei U, Muller R, Spaethe R. Antibody-based immunoadsorption as a therapeutic means. Blood Purif 1993; 11: 145-9.
    CrossrefPubMedGoogle Scholar
  • 6 Richter WO, Donner MG, Selmaier A, Hiller E, Schwandt P. Efficacy and safety of immunoglobulin apheresis. ASAIO J 1997; 43: 53-9.
    PubMedGoogle Scholar
  • 7 Calleja JL, Albillos A, Cacho G, Iborra J, Abreu L, Escartin P. Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies. J Hepatol 1996; 24: 308-12.
    CrossrefPubMedGoogle Scholar
  • 8 Thiele DL, DuCharme L, Cunningham MR, Mimms LT, Cuthbert JA, Lee WM, Combes B. Steroid therapy of chronic hepatitis: characteristics associated with response in anti-hepatitis C virus-positive and -negative patients. Am J Gastroenterol 1996; 91: 300-8.
    PubMedGoogle Scholar
  • 9 Bjorkander J, Cunningham CRundles, Lundin P, Olsson R, Soderstrom R, Hanson LA. Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency. Am J Med 1988; 84: 107-11.
    CrossrefPubMedGoogle Scholar
  • 10 Zeldis JB, Jensen P. Hepatitis C virus pathogenicity: the corner pieces of the jigsaw puzzle are found. Gastroenterology 1994; 106: 1118-20.
    PubMedGoogle Scholar